Wells Fargo & Company Zai Lab LTD Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Zai Lab LTD stock. As of the latest transaction made, Wells Fargo & Company holds 500 shares of ZLAB stock, worth $12,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 500 -0.0%

Holding current value

$12,850

Previous $8,000 50.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$15.95 - $26.8 $7,975 - $13,400	500 New	500 $8,000
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $3,203 - $4,440	141 New	141 $3,000
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $694 - $1,106	23 New	23 $0
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $28,112 - $42,489	-822 Reduced 45.12%	1,000 $34,000
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $763 - $1,639	33 Added 1.84%	1,822 $64,000
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $1,305 - $3,026	-47 Reduced 2.56%	1,789 $79,000
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $16.6 Million - $31.8 Million	-301,841 Reduced 99.4%	1,836 $116,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $28.8 Million - $48.9 Million	-274,414 Reduced 47.47%	303,677 $32 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $1.67 Million - $2.4 Million	13,309 Added 2.36%	578,091 $102 Million
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $1.58 Million - $2.4 Million	12,508 Added 2.26%	564,782 $75.4 Million
Q4 2020 Feb 09, 2021	BUY	$81.94 - $135.34 $970,005 - $1.6 Million	11,838 Added 2.19%	552,274 $74.7 Million
Q3 2020 Nov 05, 2020	BUY	$73.3 - $89.48 $6.89 Million - $8.41 Million	94,021 Added 21.06%	540,436 $44.9 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $6.23 Million - $10.5 Million	-127,628 Reduced 22.23%	446,415 $36.7 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $22.4 Million - $36.1 Million	574,043 New	574,043 $29.6 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Zai Lab LTD Transaction History